551 results Stibbe advises Wavin Advising Wavin, the leading supplier of plastic pipe systems and solutions in Europe, in relation to the EUR 523 million public offer from Mexichem for the acquisition of all outstanding shares of Wavin. Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products. Stibbe advises Beiersdorf Representing Beiersdorf during ACM proceedings into the cosmetics market resulting in a closure of the proceedings. Stibbe advises on the contemplated IPO of Agendia Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises Ballast Nedam Advising Ballast Nedam in an investigation by the ACM into possible infringements in the construction sector leading to the closure of the investigation. Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. Stibbe advises on the IPO of Tornier Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix. Stibbe advises European leading television format supplier Stibbe assisted a European leading television format supplier in various legal aspects of TV phone-in games. Setting the Stage: the European Commission’s first in-depth FSR Decision The European Commission has published its first-ever in-depth decision under the Foreign Subsidies Regulation, marking a significant milestone in understanding the application of this regulatory tool. We identify important takeaways for future practice. Pagination Previous page Page 28 Page 29 Page 30 Current page 31
Stibbe advises Wavin Advising Wavin, the leading supplier of plastic pipe systems and solutions in Europe, in relation to the EUR 523 million public offer from Mexichem for the acquisition of all outstanding shares of Wavin.
Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.
Stibbe advises Beiersdorf Representing Beiersdorf during ACM proceedings into the cosmetics market resulting in a closure of the proceedings.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises Ballast Nedam Advising Ballast Nedam in an investigation by the ACM into possible infringements in the construction sector leading to the closure of the investigation.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.
Stibbe advises European leading television format supplier Stibbe assisted a European leading television format supplier in various legal aspects of TV phone-in games.
Setting the Stage: the European Commission’s first in-depth FSR Decision The European Commission has published its first-ever in-depth decision under the Foreign Subsidies Regulation, marking a significant milestone in understanding the application of this regulatory tool. We identify important takeaways for future practice.